Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884099269> ?p ?o ?g. }
- W2884099269 endingPage "587" @default.
- W2884099269 startingPage "575" @default.
- W2884099269 abstract "Globally, the number of drug prescriptions is increasing causing more adverse drug events, which is now a significant cause of mortality, morbidity, and disability that has reached epidemic proportions. The risk of adverse drug events is correlated to very old age, multiple co-morbidities, dementia, frailty, and limited life expectancy, with the major contributor being polypharmacy. Each characteristic alters the risk–benefit balance of medications, typically reducing anticipated benefits and amplifying risk. Current clinical guidelines are based on evidence proven in younger/healthier adult populations using a single disease model and their application to older adults with multimorbidity, in whom testing has not been conducted, yields a different risk–benefit prospect and makes inappropriate medication use and polypharmacy inevitable. Applying inappropriate clinical practice guidelines to older adults is antithetical to good healthcare, is likely to increase health inequity, and is associated with substantial negative clinical, economic, and social implications for health systems. The casualties are on the scale of a war or epidemic, yet are usually invisible in measures of healthcare quality and formal recommendations. Radical and rapid action is required to achieve a better quality of life for older populations and to remain true to the principles of medical professionalism and evidence-based medicine that place patients’ interests and autonomy at the fore. This first International Group for Reducing Inappropriate Medication Use & Polypharmacy position statement briefly details the causes, consequences, and extent of inappropriate medication use and polypharmacy. This article outlines current strategies to reduce inappropriate medication use, provides evidence for their effect, and then proposes recommendations for moving forward with 10 recommendations for action and 12 recommendations for research. We conclude that an urgent integrated effort to reduce inappropriate medication use and polypharmacy should be a leading global target of the highest priority. The cornerstone of this position statement from the International Group for Reducing Inappropriate Medication Use & Polypharmacy is the understanding that without evidence of definite relevant benefit, when it comes to prescribing, for many older patients ‘less is more’. This approach differs from most other current recommendations and guidance in medical care, as the focus is on what, when, and how to stop, rather than on when to start medications/interventions. Disrupting the framework that indiscriminately applies standard guidelines to older adults requires a new approach that better serves patients with multimorbidity. This transition requires a shift in medical education, research, and diagnostic frameworks, and re-examination of the measures used as quality indicators. In achieving this objective, we promote a return to some of the original concepts of evidence-based medicine: which considers scientific data (where it exists), clinical judgment, patient/family preference, and context. A shift is needed: from the current model that focuses on single conditions to one that simultaneously considers multiple conditions and patient priorities. This approach reframes the clinician’s role as a professional providing care, rather than a disease technician." @default.
- W2884099269 created "2018-08-03" @default.
- W2884099269 creator A5003486011 @default.
- W2884099269 creator A5033350951 @default.
- W2884099269 creator A5044282024 @default.
- W2884099269 creator A5049733443 @default.
- W2884099269 creator A5062583220 @default.
- W2884099269 creator A5071924399 @default.
- W2884099269 creator A5073336923 @default.
- W2884099269 creator A5073952805 @default.
- W2884099269 date "2018-07-01" @default.
- W2884099269 modified "2023-10-11" @default.
- W2884099269 title "International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action" @default.
- W2884099269 cites W1503012464 @default.
- W2884099269 cites W1520227242 @default.
- W2884099269 cites W1530712258 @default.
- W2884099269 cites W1540086567 @default.
- W2884099269 cites W1607171811 @default.
- W2884099269 cites W16655179 @default.
- W2884099269 cites W172609984 @default.
- W2884099269 cites W1762214373 @default.
- W2884099269 cites W1836605791 @default.
- W2884099269 cites W1846375292 @default.
- W2884099269 cites W1963867953 @default.
- W2884099269 cites W1964778524 @default.
- W2884099269 cites W1969388541 @default.
- W2884099269 cites W1969879564 @default.
- W2884099269 cites W1975482756 @default.
- W2884099269 cites W1979446181 @default.
- W2884099269 cites W1979735814 @default.
- W2884099269 cites W1986689424 @default.
- W2884099269 cites W1991148521 @default.
- W2884099269 cites W1991617773 @default.
- W2884099269 cites W1995157767 @default.
- W2884099269 cites W1997677647 @default.
- W2884099269 cites W1997810742 @default.
- W2884099269 cites W1999896751 @default.
- W2884099269 cites W2000436249 @default.
- W2884099269 cites W2004663173 @default.
- W2884099269 cites W2005183386 @default.
- W2884099269 cites W2007108401 @default.
- W2884099269 cites W2010726073 @default.
- W2884099269 cites W2013331409 @default.
- W2884099269 cites W2013489663 @default.
- W2884099269 cites W2016515948 @default.
- W2884099269 cites W2017187199 @default.
- W2884099269 cites W2019286098 @default.
- W2884099269 cites W2019992226 @default.
- W2884099269 cites W2020494695 @default.
- W2884099269 cites W2021000396 @default.
- W2884099269 cites W2021046234 @default.
- W2884099269 cites W2021192099 @default.
- W2884099269 cites W2026375486 @default.
- W2884099269 cites W2028297647 @default.
- W2884099269 cites W2028984320 @default.
- W2884099269 cites W2029549566 @default.
- W2884099269 cites W2030434108 @default.
- W2884099269 cites W2034058040 @default.
- W2884099269 cites W2034283688 @default.
- W2884099269 cites W2038440539 @default.
- W2884099269 cites W2039965635 @default.
- W2884099269 cites W2043694482 @default.
- W2884099269 cites W2046452022 @default.
- W2884099269 cites W2059139929 @default.
- W2884099269 cites W2059901490 @default.
- W2884099269 cites W2062836608 @default.
- W2884099269 cites W2064470295 @default.
- W2884099269 cites W2064879830 @default.
- W2884099269 cites W2070961119 @default.
- W2884099269 cites W2076831846 @default.
- W2884099269 cites W2079560112 @default.
- W2884099269 cites W2082303471 @default.
- W2884099269 cites W2084252616 @default.
- W2884099269 cites W2084734925 @default.
- W2884099269 cites W2085842968 @default.
- W2884099269 cites W2086743669 @default.
- W2884099269 cites W2087574663 @default.
- W2884099269 cites W2088141733 @default.
- W2884099269 cites W2090602898 @default.
- W2884099269 cites W2095649880 @default.
- W2884099269 cites W2096245064 @default.
- W2884099269 cites W2098891980 @default.
- W2884099269 cites W2106114209 @default.
- W2884099269 cites W2106952837 @default.
- W2884099269 cites W2107794933 @default.
- W2884099269 cites W2113021977 @default.
- W2884099269 cites W2113525252 @default.
- W2884099269 cites W2118050080 @default.
- W2884099269 cites W2118298006 @default.
- W2884099269 cites W2118746357 @default.
- W2884099269 cites W2119504763 @default.
- W2884099269 cites W2121069368 @default.
- W2884099269 cites W2126445511 @default.
- W2884099269 cites W2127960841 @default.
- W2884099269 cites W2128061856 @default.
- W2884099269 cites W2128662797 @default.
- W2884099269 cites W2130510785 @default.
- W2884099269 cites W2131482082 @default.